U.S. Markets closed

Celldex Therapeutics (CLDX) Worth Watching: Stock Rises 9.1%

Zacks Equity Research

Celldex Therapeutics, Inc. (CLDX) was a big mover last session, as its shares rose a little over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $12.96 to $15.47 in the past one-month timeframe.

In the last 30 days, the company witnessed a mixed estimate revision of three increases and three decreases while the Zacks Consensus Estimate remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Celldex Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
    
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

CELLDEX THERAPEUTICS INC (CLDX): Free Stock Analysis Report


Zacks Investment Research